OpenAI drops GPT-Rosalind to speed up drug discovery
OpenAI just unveiled GPT-Rosalind, a frontier reasoning model purpose-built for biology, genomics, and drug discovery. It beats GPT-5.4 on six of 11 LABBench2 tasks and landed in the 95th percentile against human experts on RNA sequence prediction. While model access requires trusted vetting, OpenAI also dropped a free research plugin on GitHub.